- Home
- INTU vs MRK Comparison
INTU vs MRK Comparison
Compare INTU & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTU
- MRK
- Stock Information
- Founded
- INTU 1983
- MRK 2000
- Country
- INTU United States
- MRK United States
- Employees
- INTU N/A
- MRK N/A
- Industry
- INTU Computer Software: Prepackaged Software
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- INTU Technology
- MRK Health Care
- Exchange
- INTU Nasdaq
- MRK Nasdaq
- Market Cap
- INTU 185.3B
- MRK 218.8B
- IPO Year
- INTU 1993
- MRK N/A
- Fundamental
- Price
- INTU $655.75
- MRK $84.10
- Analyst Decision
- INTU Strong Buy
- MRK Buy
- Analyst Count
- INTU 18
- MRK 15
- Target Price
- INTU $812.28
- MRK $105.29
- AVG Volume (30 Days)
- INTU 1.5M
- MRK 10.2M
- Earning Date
- INTU 11-20-2025
- MRK 10-30-2025
- Dividend Yield
- INTU 0.73%
- MRK 3.86%
- EPS Growth
- INTU 31.06
- MRK 58.06
- EPS
- INTU 13.67
- MRK 7.56
- Revenue
- INTU $18,831,000,000.00
- MRK $64,235,000,000.00
- Revenue This Year
- INTU $14.59
- MRK $1.82
- Revenue Next Year
- INTU $12.50
- MRK $5.10
- P/E Ratio
- INTU $48.31
- MRK $11.10
- Revenue Growth
- INTU 15.63
- MRK 1.68
- 52 Week Low
- INTU $532.65
- MRK $73.31
- 52 Week High
- INTU $813.70
- MRK $105.07
- Technical
- Relative Strength Index (RSI)
- INTU 44.88
- MRK 43.05
- Support Level
- INTU $653.54
- MRK $82.01
- Resistance Level
- INTU $676.19
- MRK $88.30
- Average True Range (ATR)
- INTU 13.58
- MRK 2.01
- MACD
- INTU -0.17
- MRK -0.51
- Stochastic Oscillator
- INTU 29.85
- MRK 22.71
About INTU Intuit Inc.
Intuit serves small and midsize businesses with accounting software QuickBooks and online marketing platform Mailchimp. The company also operates retail tax filing tool TurboTax, personal finance platform Credit Karma, and a suite of professional tax offerings for accountants. Founded in the mid-1980s, Intuit enjoys a dominant market share for small-to-midsize business accounting and self-serve tax filing in the US.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).